About

About Parapet

Scientific Study

Partnering on design and implementation of scientific studies.

Policy Analysis

Identification and analysis of policies in support of improved outcomes.

Writing

Development of lay and technical written works, such as advocacy materials and academic manuscripts.

Ellen P. Carlin, DVM

Ellen has been consulting since 2011 and launched Parapet Science & Policy Consulting in 2023. She is a veterinarian and policy expert who provides subject matter expertise for clients on emerging infectious disease, zoonotic pathogens, and policy opportunities to prevent pandemics. She has worked for the U.S. government, in clinical veterinary medicine, and in field settings to advance human and animal health.


Her work explores the underpinnings of infectious disease and policy interventions to prevent and manage infectious outbreaks. She supports the implementation of research projects, publishing results, developing policy priorities, and teaching the next generation of scientists and policy professionals. She is a lecturer at the Cornell University College of Veterinary Medicine and a research fellow with EcoHealth Alliance, and previously held a faculty position in the Department of Microbiology and Immunology at Georgetown University. In 2013, Ellen completed a fellowship at the U.S. Food and Drug Administration Center for Veterinary Medicine. From 2007-2013, she staffed the Ranking Member and then Chairman of the House Committee on Homeland Security, where she covered medical preparedness, biodefense, and science and technology. She maintains her license to practice veterinary medicine, and has worked or volunteered as a small animal clinical veterinarian to serve her interests in animal welfare, public health, and parasitology.


Ellen’s academic work has been published in journals including Health Security, Advances in Parasitology, and Tropical Medicine and Infectious Disease, and her lay writing has been published in the Washington Post, Think Global Health, The Hill, and other platforms read by policymakers and their staff.


Ellen received a bachelor’s of science in biology from the College of Mount Saint Vincent and a doctorate in veterinary medicine from the Cornell College of Veterinary Medicine.


See below for some of Ellen's past and current projects.


Disasters and decisions

Examining twenty years of disasters from 9/11 to COVID-19, Jeff Schlegelmilch and I show how flawed incentive structures make the world more vulnerable when catastrophe strikes. Offering a comprehensive look at disaster governance, Catastrophic Incentives provides timely recommendations for reimagining systems and institutions so that they are better equipped to manage twenty-first-century threats. Published by Columbia University Press in September 2023.

Learn more

Infection at the animal-human interface

Working with principal investigator Dr. Claire Standley at Georgetown University and NGO partner Santé Plus, we are studying the presence and transmission of fever-causing pathogens in Guinea. Our research is examining samples from people, livestock, bats, rodents, and dogs to understand the connections. See more about the Fever Project and the other great work of the Standley Lab by clicking below.

Learn more

Congress and pandemics

Despite decades of U.S. government attention to biological threats, COVID-19 revealed substantial deficits in preparedness.  Ryan Remmel and I catalogued and quantified information delivered to members of Congress that would enable them to determine their level of concern about emerging infectious disease risk and direct a course of action. Our results suggest that absence of lawmaker knowledge of the risks was not the cause of the United States’ lack of preparedness. 

Learn more

Eradicating Guinea worm disease

Guinea worm disease is a neglected tropical disease that was targeted for eradication several decades ago because of its limited geographical distribution, predictable seasonality, straightforward diagnosis, and exclusive infection of humans. Led by Matt Boyce, we reviewed epidemiological evidence that could support the utility of a One Health approach for GWD control in the six countries that have reported human GWD cases since 2015—Angola, Cameroon, Chad, Ethiopia, Mali, and South Sudan.

Learn more

National biodefense

In 2014, I helped to establish the Blue Ribbon Study Panel on Biodefense, which later became the Bipartisan Commission on Biodefense, and draft the group's first report, A National Blueprint for Biodefense. The work of the Commission continues under the leadership of the commissioners and executive director Dr. Asha George.

Learn more
Share by: